Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

Research output: Contribution to journalLetterAcademicpeer-review

2 Citations (Scopus)
59 Downloads (Pure)
Original languageEnglish
Pages (from-to)1049–1052
Number of pages4
JournalEuropean Journal of Heart Failure
Volume23
Issue number6
Early online date11-May-2021
DOIs
Publication statusPublished - Jun-2021

Keywords

  • DAPAGLIFLOZIN
  • RISK

Cite this